Back to Journals » OncoTargets and Therapy » Volume 13

RETRACTED ARTICLE: Long Noncoding RNA ST7-AS1 Upregulates TRPM7 Expression by Sponging microRNA-543 to Promote Cervical Cancer Progression

Authors Qi H, Lu L, Wang L

Received 6 April 2020

Accepted for publication 21 June 2020

Published 27 July 2020 Volume 2020:13 Pages 7257—7269

DOI https://doi.org/10.2147/OTT.S253868

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Prof. Dr. Geoffrey Pietersz



This paper has been retracted.

Qi H, Lu L, Wang L. Onco Targets Ther. 2020;13:7257–7269.

We, the Editor and Publisher of OncoTargets and Therapy are retracting the published article. Since publication, concerns have been raised about the duplication of images in this article with those from other unrelated articles. Specifically,

  • The image from Figure 4E, SiHa, si-NC, has been duplicated with the image from Figure 4E, T98, siNC, from Yang H, Song Z, Wu X, Wu Y, Liu C. MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway. Onco Targets Ther. 2019;12:5563–5575. https://doi.org/10.2147/OTT.S204715 (RETRACTED).
  • The image from Figure 5C, SiHa, si-ST7-AS1+miR-543 inhibitor, has been duplicated with the image from Figure 6C, MGC-803, si-NC, from Wang X, Chen X, Tian Y, Jiang D, Song Y. Long Noncoding RNA RGMB-AS1 Acts as a microRNA-574 Sponge Thereby Enhancing the Aggressiveness of Gastric Cancer via HDAC4 Upregulation. Onco Targets Ther. 2020;13:1691–1704. https://doi.org/10.2147/OTT.S234144 (RETRACTED).
  • The image from Figure 5D, C-33A, si-ST7-AS1+miR-543 inhibitor, has been duplicated with the image from Figure 4F, U2OS, si-NC, from Zhao X, Li J, Yu D. MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway. Int J Mol Med. 2019;44:1833–1843. https://doi.org/10.3892/ijmm.2019.4333 (RETRACTED).

When approached for an explanation, the authors have been unable to address the concerns raised and have not been able to provide sufficient original data from their study. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors listed in this publication have been informed.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.